Isobavachalcone ameliorates the progression of osteoarthritis by suppressing NF-κB signaling pathway
- 24 April 2023
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 119, 110102
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health of the People's Republic of China (LHGJ20210035)
- Henan Provincial Science and Technology Research Project (222102310124)
This publication has 40 references indexed in Scilit:
- The Role of Changes in Extracellular Matrix of Cartilage in the Presence of Inflammation on the Pathology of OsteoarthritisBioMed Research International, 2013
- Isobavachalcone suppresses expression of inducible nitric oxide synthase induced by Toll-like receptor agonistsInternational Immunopharmacology, 2013
- Synovial inflammation, immune cells and their cytokines in osteoarthritis: a reviewOsteoarthritis and Cartilage, 2012
- Role of proinflammatory cytokines in the pathophysiology of osteoarthritisNature Reviews Rheumatology, 2010
- The role of synovitis in pathophysiology and clinical symptoms of osteoarthritisNature Reviews Rheumatology, 2010
- Abrogation of Akt signaling by Isobavachalcone contributes to its anti-proliferative effects towards human cancer cellsCancer Letters, 2010
- Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytesArchives of Biochemistry and Biophysics, 2009
- Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritisOsteoarthritis and Cartilage, 2008
- Osteoarthritis, angiogenesis and inflammationRheumatology, 2004
- NF-κB: a key role in inflammatory diseasesJournal of Clinical Investigation, 2001